Acasti Pharma Inc (ACST.O)

ACST.O on Consolidated Issue listed on NASDAQ Capital Market

3.85USD
1 Aug 2013
Price Change (% chg)

$-0.18 (-4.47%)
Prev Close
$4.03
Open
$4.04
Day's High
$4.09
Day's Low
$3.85
Volume
14,963
Avg. Vol
20,947
52-wk High
$4.20
52-wk Low
$1.61

ACST.O

Chart for ACST.O

About

Acasti Pharma Inc. (Acasti) is engaged in developing a product portfolio of long-chain omega-3 phospholipids. Acasti is a majority owned subsidiary of Neptune Technologies and Bioressources Inc. (Neptune). The Company has one operating segment: the development and commercialization of pharmaceutical applications of its licensed... (more)

Overall

Beta: --
Market Cap (Mil.): $331.88
Shares Outstanding (Mil.): 79.97
Dividend: --
Yield (%): --

Financials

  ACST.O Industry Sector
P/E (TTM): -- 37.93 37.76
EPS (TTM): -0.10 -- --
ROI: -66.94 19.48 18.76
ROE: -66.94 20.17 19.59
Search Stocks

Earnings vs. Estimates

Search Stocks